PER 2.47% 7.9¢ percheron therapeutics limited

Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 854 Posts.
    lightbulb Created with Sketch. 329
    review and approval is between 60-106 days with allowance for modifications. Trials can still start this year
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(2.47%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $230.1K 2.904M

Buyers (Bids)

No. Vol. Price($)
1 51000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 163520 2
View Market Depth
Last trade - 15.57pm 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.